Cryptococcal meningitis presenting with acute hearing loss

2021 ◽  
Vol 14 (5) ◽  
pp. e242059
Author(s):  
Aleem Azal Ali ◽  
Naji Maaliki ◽  
Monique Oye ◽  
Carmen Liliana Isache
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Young Woman ◽  
Cryptococcal Meningitis ◽  
Sensorineural Hearing ◽  
Initial Symptom ◽  
Neck Stiffness ◽  
Bilateral Hearing Loss ◽  
Acute Hearing Loss

Reversible sensorineural hearing loss is a recognised complication of cryptococcal meningitis. Cryptococcal meningitis typically presents with usual symptoms of fever, headache and neck stiffness. This case highlights acute, profound, bilateral hearing loss as the initial symptom and presentation of cryptococcal meningitis in a young woman, who was later diagnosed with AIDS.

Ears

2020 ◽  
Author(s):  
Peter Pruitt ◽  
Thomas Osborne Stair
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Acoustic Trauma ◽  
Tympanic Membrane Perforation ◽  
Sensorineural Hearing ◽  
Hearing Disorders ◽  
High Frequency Hearing Loss ◽  
Membrane Perforation ◽  
Acute Hearing Loss ◽  
Conductive Hearing

As the structure of the ear is made of little more than cartilage, a limited blood supply, and a thin layer of skin, trauma in this area can easily manifest from a variety of causes. Some common examples of trauma involve laceration, piercing (intentional or otherwise), infection causing chondritis, blunt trauma causing necrosis, rupture of the tympanic membrane, perforation of the ear drum, and acoustic trauma that may result in hearing disorders such as tinnitus and high-frequency hearing loss. Acute hearing loss shows in two forms: conductive hearing loss and sensorineural hearing loss, the latter of which is caused by damage to the anatomic or neurologic structures of the ear dedicated to hearing. Sensorineural hearing loss generally has a poor prognosis and mandates prompt referral to an otolaryngologist.  This review contains 4 figures, 13 tables, and 32 references. Keywords: Ear, auricular canal, trauma, otitis media, otitis externa, hearing loss, mastoiditis, cerumen, impaction

Reversible hearing loss following cryptococcal meningitis: case study

2016 ◽  
Vol 130 (7) ◽  
pp. 691-695 ◽  
Author(s):  
W L Neo ◽  
N Durisala ◽  
E C Ho
Keyword(s):  
Hearing Loss ◽  
Case Report ◽  
Bacterial Meningitis ◽  
Sensorineural Hearing Loss ◽  
Cochlear Implantation ◽  
Cryptococcal Meningitis ◽  
Sudden Onset ◽  
Sensorineural Hearing ◽  
Labyrinthitis Ossificans

AbstractBackground:Sensorineural hearing loss is a recognised complication of cryptococcal meningitis. The mechanism of hearing loss in patients with cryptococcal meningitis is different from that in bacterial meningitis.Case report:An immune-competent man with cryptococcal meningitis presented with sudden onset, bilateral, severe to profound sensorineural hearing loss and vestibular dysfunction. He was initially evaluated for cochlear implantation. However, he had a significant recovery; he no longer required surgery and was able to cope without a hearing aid.Conclusion:Typically, cochlear implantation is performed with some urgency in patients with hearing loss post-bacterial meningitis, because of the risk of labyrinthitis ossificans. However, this process has not been described in patients with cryptococcal meningitis. Furthermore, patients with hearing loss associated with cryptococcal meningitis have shown varying degrees of reversibility. In this case report, hearing loss from cryptococcal meningitis is compared with that from bacterial meningitis, and the need for cochlear implantation in patients with cryptococcal meningitis is discussed.

Cochlear Implantation in Sudden Bilateral Sensorineural Hearing Loss

1998 ◽  
Vol 77 (4) ◽  
pp. 300-303 ◽  
Author(s):  
Eric W. Sargent ◽  
Douglas L. Beck
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Cochlear Implantation ◽  
Sudden Sensorineural Hearing Loss ◽  
Sensorineural Hearing ◽  
Bilateral Hearing Loss ◽  
Significant Recovery ◽  
Open Set ◽  
Bilateral Sensorineural Hearing Loss

Although 1–4% of all cases of sudden sensorineural hearing loss (SSHL) are bilateral, all such patients reported to date have experienced significant recovery of hearing in at least one ear. We report a case of profound, bilateral idiopathic SSHL without recovery which was treated with cochlear implantation; the first such report to our knowledge. The patient achieved open-set spondee recognition. Individuals with sudden bilateral hearing loss in whom treatable causes have been eliminated may benefit from cochlear implantation.

scholarly journals Sensorineural Hearing Loss as the Prominent Symptom in Meningeal Carcinomatosis

2021 ◽  
Vol 28 (5) ◽  
pp. 3240-3250
Author(s):  
Xiaoqin Huang ◽  
Yu Jia ◽  
Lidong Jiao
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Cranial Nerves ◽  
Case Fatality ◽  
Whole Brain Radiotherapy ◽  
Meningeal Carcinomatosis ◽  
Sensorineural Hearing ◽  
Initial Symptom ◽  
Brain Radiotherapy ◽  
Total Deafness

Sensorineural hearing loss (SNHL) has been reported rarely in patients with meningeal carcinomatosis (MC). We summarized the clinical data of eight MC patients with SNHL and 35 patients reported from publications. In the eight patients with SNHL, the medium onset age was 48 (range from 37 to 66) years and six (75%) were male. Seven (87.5%) suffered from headaches as the initial symptom, and they experienced SNHL during the first two months after the occurrence of headaches (0.5 to 2 months, average 1.5 months). The audiogram configuration was flat in three patients (37.5%) and showed total deafness in five patients (62.5%). The damage of cranial nerves VI (abducens) was observed in six patients (75%), and four patients (50%) had cranial nerves VII (facial) injury during the disease course. The percentage of damage of cranial nerves was higher than the patients without SNHL (VIth, 75.0% vs. 13.3%, p = 0.002 and VIIth 50.0% vs. 6.7%, p = 0.012). Four (50%) patients suffered from lung adenocarcinoma as primary tumor, two (25%) experienced stomach adenocarcinoma, one had colon cancer, and one patient was unknown. The symptom of SNHL improved after individualized therapy in four patients (focal radiotherapy and chemotherapy for three patients and whole brain radiotherapy for one patient), but all passed away from 2 to 11 months after diagnosis. Total deafness and flat hearing loss in audiogram were the common types of SNHL resulting from MC. MC patients with SNHL were more likely to suffer from the damage of other cranial nerves, especially to cranial nerves VI and VII. Treatment might improve SNHL, but not improve the case fatality rate.

scholarly journals Association of multiple sclerosis and sudden sensorineural hearing loss

2016 ◽  
Vol 2 ◽  
pp. 205521731665215 ◽  
Author(s):  
S Atula ◽  
ST Sinkkonen ◽  
R Saat ◽  
T Sairanen ◽  
T Atula
Keyword(s):  
Multiple Sclerosis ◽  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Normal Population ◽  
Cranial Nerves ◽  
Sudden Sensorineural Hearing Loss ◽  
Sensorineural Hearing ◽  
University Hospital ◽  
Initial Symptom ◽  
Mri Findings

Background Multiple sclerosis (MS) may affect other cranial nerves besides the optic nerve. Sudden sensorineural hearing loss (SSHL), possibly caused by a deficit in the auditory tract, including the vestibulocochlear nerve, is sometimes associated with MS. Objectives We aimed to assess the incidence of SSHL among MS patients, its frequency as an initial symptom of MS, and magnetic resonance imaging (MRI) findings associated with SSHL in MS. Methods We collected retrospectively all patients diagnosed with MS and SSHL at the Helsinki University Hospital between 2004 and 2014. Patients with both diagnoses were re-evaluated using hospital medical records, audiograms and head MRI scans. Results A total of 2736 patients were diagnosed with MS, 1581 patients with SSHL, and 18 patients (0.7% of all MS patients) with both; two patients presented with SSHL as an initial symptom of MS. The annual incidence of SSHL was 59.8/100 000 (95% confidence interval (CI) 37.7–94.9) in MS patients, and 12.4/100 000 (95% CI 11.8–13.0) in the normal population. Conclusion SSHL is a rare symptom of MS and is even less frequent as an initial symptom. Its incidence in MS patients, however, markedly exceeds that in the normal population.

Angiostrongylus eosinophilic meningitis associated with sensorineural hearing loss

2004 ◽  
Vol 118 (1) ◽  
pp. 57-58 ◽  
Author(s):  
Verajit Chotmongkol ◽  
Kwanchanok Yimtae ◽  
Pewpan M. Intapan
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Chronic Headache ◽  
Sensorineural Hearing ◽  
Eosinophilic Meningitis ◽  
Neck Stiffness

A 59-year-old woman who presented with chronic headache, neck stiffness and left-sided hearing loss is reported. The diagnosis of angiostrongylus eosinophilic menigitis was made. The patient improved after treatment with prednisolone, including hearing.Angiostrongylus eosinophilic meningitis associated with sensorineural hearing loss has not previously been reported.

Sudden Sensorineural Hearing Loss in Lupus Erythematosus Associated with Antiphospholipid Syndrome: Case Report and Review

2005 ◽  
Vol 114 (3) ◽  
pp. 214-218 ◽  
Author(s):  
Giacomo Ceroni Compadretti ◽  
Cristina Brandolini ◽  
Ignazio Tasca
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Lupus Erythematosus ◽  
Anticardiolipin Antibody ◽  
Anticardiolipin Antibodies ◽  
Sudden Sensorineural Hearing Loss ◽  
Sensorineural Hearing ◽  
Initial Symptom ◽  
Good Clinical Condition ◽  
The Right

Systemic lupus erythematosus is a disease of unknown cause that manifests with tissue and cellular alterations due to the deposition of antibodies and pathogenic immune complexes. The disease can be associated with anticardiolipin antibody syndrome, a disorder of recurrent vascular thrombosis and thrombocytopenia associated with a persistent anticardiolipin test positivity. In this report, we describe the case of a young woman affected by lupus erythematosus and positive for anticardiolipin antibodies who was brought to our observation for a sudden sensorineural hearing loss in the right ear. The patient was successfully treated with osmotic therapy and, 13 months after the initial symptom, is now in good clinical condition with no recurrence of the hearing loss and normal bilateral hearing. Together with a critical review of the pertinent literature, this rare clinical case led us to formulate some original comments.

scholarly journals Bilateral Hearing Loss after Spinal Anaesthesia

1970 ◽  
Vol 5 (1) ◽  
pp. 53-55
Author(s):  
Masud Ahmed ◽  
Md Rezaul Alam Chowdhury ◽  
Md Shahidul Islam ◽  
Salahuddin Ahmmed
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Spinal Anaesthesia ◽  
Rare Complication ◽  
Sudden Sensorineural Hearing Loss ◽  
Sensorineural Hearing ◽  
Bilateral Hearing Loss ◽  
Diagnosis And Management

Mild and transient hearing deficiency is not very uncommon after anaesthesia which improves before patient is fully aware of the problem. But complete prolong bilateral hearing loss after spinal anaesthesia is extremely rare complication, which falls in the category of sudden sensorineural hearing loss (SSNHL). The diagnosis and management of SSNHL is still controversial.   doi: 10.3329/jafmc.v5i1.2854 JAFMC Bangladesh. Vol 5, No 1 (June) 2009 pp.53-55

Imaging of the Temporal Bone

2020 ◽  
Author(s):  
Peter Pruitt
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Acoustic Trauma ◽  
Tympanic Membrane Perforation ◽  
Sensorineural Hearing ◽  
Hearing Disorders ◽  
High Frequency Hearing Loss ◽  
Membrane Perforation ◽  
Acute Hearing Loss ◽  
Conductive Hearing

As the structure of the ear is made of little more than cartilage, a limited blood supply, and a thin layer of skin, trauma in this area can easily manifest from a variety of causes. Some common examples of trauma involve laceration, piercing (intentional or otherwise), infection causing chondritis, blunt trauma causing necrosis, rupture of the tympanic membrane, perforation of the ear drum, and acoustic trauma that may result in hearing disorders such as tinnitus and high-frequency hearing loss. Acute hearing loss shows in two forms: conductive hearing loss and sensorineural hearing loss, the latter of which is caused by damage to the anatomic or neurologic structures of the ear dedicated to hearing. Sensorineural hearing loss generally has a poor prognosis and mandates prompt referral to an otolaryngologist.  This review contains 4 figures, 13 tables, and 32 references. Keywords: Ear, auricular canal, trauma, otitis media, otitis externa, hearing loss, mastoiditis, cerumen, impaction

Ototoxicity and Teprotumumab

2021 ◽  
pp. 000348942110427
Author(s):  
Julie Highland ◽  
Steven Gordon ◽  
Deepika Reddy ◽  
Neil Patel
Keyword(s):  
Monoclonal Antibody ◽  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Sensorineural Hearing ◽  
Objective Data ◽  
Tertiary Referral ◽  
Bilateral Hearing Loss ◽  
Tertiary Referral Center ◽  
Graves Ophthalmopathy ◽  
Oral Corticosteroids

Objectives: Teprotumumab, a novel monoclonal antibody, targets the insulin-like growth factor 1 (IGF-1) receptor. IGF-1 receptors, found in muscle and fat adjacent to the eye and implicated in Graves Ophthalmopathy, are also in the cochlea. In clinical trials, 5 participants reported self-limited audiologic symptoms but there are no objective data in the literature. The aim of this report is to describe one of the first known cases of teprotumumab-induced irreversible sensorineural hearing loss. Methods: Case report at a tertiary referral center Results: A 61 year old female with Graves ophthalmopathy presented with bilateral hearing loss, sound distortion, and tinnitus following treatment with teprotumumab. Audiogram showed mild sloping to moderately-severe sensorineural hearing loss. Repeat audiometry obtained 4 months after cessation of teprotumumab and treatment with oral corticosteroids was unchanged. Conclusions: This is one of the first descriptive cases of ototoxicity resulting in irreversible sensorineural hearing loss in the setting of treatment with teprotumumab. Periodic audiologic evaluations should be recommended to patients on teprotumumab.

Sign in / Sign up

Export Citation Format

Share Document